Eyenovia, Inc.’s Post

My first podcast! I had so much fun with Kyle Kruse 🚀 and Richard Meiklejohn talking about Imricor and how we are advancing medicine with our technology. Thanks guys for the invitation! The link is below if you are interested in learning about what we are doing.

Lunit Global strikes again! Hot on the heels of their acquisition of Volpara, Lunit has now partnered with Radiobotics to distribute their innovative bone X-ray products, starting with their flagship fracture detection software 🚀 This strategic partnership allows Lunit to leverage Radiobotics' expertise in bone radiography, enhancing their own chest radiography solutions. This combination aims to provide more comprehensive coverage in conventional radiography, a major component of radiology volumes. Currently, Lunit and GLEAMER are the only two top-tier companies known to offer integrated AI-driven solutions for both bone and chest radiography. Interestingly and according to the press release, the agreement grants Lunit distribution rights for Radiobotics' products, with no reciprocal distribution rights for Radiobotics to Lunit's technology. This development marks a dynamic period for radiology AI startups, where collaboration and mergers are becoming pivotal in enhancing their market offerings and bolstering financial stability. Find out more in the press release linked in the comments below! 👇 #Radiology #AI #Startups #Partnership

🚀 CroiValve in The Times! 📰 Thrilled to see our medtech startup, CroiValve, featured for revolutionizing heart condition treatment. This is just the start—big things ahead! Check out the article here: https://lnkd.in/eya4GRve #CroiValve #MedTech #MedTechSyndicate #HealthcareInnovation

🌟 Introducing Anorit Medical: Empowering bystander involvement in Cardiac Arrest 🌟 Welcome to Anorit Medical! We are happy to have you with us on this exciting journey! Let us introduce ourselves and share what our company is all about. 🚀 At Anorit Medical, we believe that everyone can be a lifesaver. Our mission is to empower bystanders to provide early ventilation to Cardiac Arrest patients, thus improving their chances of survival and return to a good quality of life. In those critical moments, every second counts, and we want to ensure that anyone, anywhere, can make a difference. Our founding team of three — Andreas, Minik and Sotiria, comes from diverse backgrounds, bringing together expertise from healthcare, design and the medical device industry, enriched by our different cultural perspectives and insights. 👥 Meet Our Founders: - Minik Nørreslet - CTO: A skilled Osteopath with a passion for engineering and a business drive -Sotiria Athanasiadou - CEO: A seasoned medtech professional known for a strong grit and commitment to improving patients' lives - Andreas Konradsen - CPO: An experienced industrial designer with a vision to transforming healthcare with accessible and effective devices We are still at the beginning of our ventures, but we are dedicated to making a real impact and we would love to have you along with us for the ride. Together, we can make a difference to many people's lives! #MeetTheTeam #Startup #HealthcareInnovation #MedTech #Entrepreneurship #HealthcareTechnology #Innovation #StartupCommunity

SigTuple Secures $4 Million Funding Round SigTuple, a healthcare technology startup, has successfully raised $4 million in its latest funding round. The investment will be utilized to further develop their AI-driven medical diagnostic solutions, focusing on automated analysis of medical imaging and digital pathology. This funding will also help SigTuple enhance their product offerings and expand their market presence. Funding Amount: SigTuple raised $4 million. Purpose: To develop AI-driven medical diagnostic solutions. Focus: Automated analysis of medical imaging and digital pathology. Impact: Enhancing product offerings and expanding market reach. #Zedvox #CustomerEngagement #BusinessGrowth #BoostYourBusiness #ZedvoxForSuccess #Innovation #Startup #FundingNews #SigTuple #HealthcareTech #AIDriven #MedicalDiagnostics #DigitalPathology

Health tech startup ThinkSono secures £2.1m funding for AI-driven ultrasound efficiency improvement. Founded in 2016, ThinkSono develops AI-powered imaging tools for ultrasound scans in healthcare. Join for More: https://lnkd.in/e_aPBGvm Flagship product focuses on software for non-ultrasound-trained staff to detect deep vein thrombosis (DVT) blood clots. ThinkSono's CMO, Prof. Michael Blaivas, highlights the potential to revolutionize patient care with quicker DVT diagnosis. Investment led by Id4 Ventures, joined by Brandenburg Kapital, Calm Storm Ventures, Dubai Angel Investors, and others. CEO Fouad Al Noor emphasizes the funding's role in advancing medical imaging tech and improving patient outcomes. Total funding raised by ThinkSono now stands at £5m, fueling its mission to transform healthcare.

Join the conversation this Thursday as we unwind the story of Aether Biomedical with Dr. Faith Jiwakhan, co-founder and CCO of Aether Biomedical. Aether Biomedical is a pioneering startup that crafts prosthetic, robotic hands for amputees. Get ready to be inspired by every chapter we unfold to dive deep into the story of Aether. They are making a remarkable impact with their strongest product: Zeus! 😉 More on this later on April 10, 2024! Follow Newzchain for all the updates. #AetherBiomedical #RoboticHands #TheNewzchainPodcast #Newzchain

In the last few days, SamanTree Medical SA, Asceneuron SA, Regenosca SA, DemoSquare and Freesuns have raised several million Swiss Francs 🙌 Despite the uncertain times, Startupticker.ch's latest Swiss Venture Capital Report highlights the region's stability in terms of funding, which these new rounds demonstrate: - SamanTree Medical SA raises $14M to support global expansion and innovation in surgical treatment - Lausanne-based Asceneuron SA raises $100 million for its groundbreaking treatments of neurodegenerative diseases - Regenosca SA closes a CHF 1M pre-seed round for its non-invasive regenerative tissue implants - DemoSquare Closes CHF 1.2 Million Pre-Seed Round - CHF 1 million for Freesuns' solar roof tiles Patrick Barbey points out: "Vaud's innovative fabric continues to show its dynamism during this summer break, with several successive fundraisings, the majority in the life sciences sector. This is due to an ideal setting, with top-class laboratories and a rich academic network, combined with talented entrepreneurs, confirming a trend that has been in place for over ten years." Read more 👉 https://lnkd.in/di2EMDZ9 #VDTech #SwissTech

Neuspera Medical Inc. closed its Series D funding round, raising $23 million 💰. The funding was led by Vertex Ventures HC and Treo Ventures, with participation from Action Potential Venture Capital, Windham Venture Partners, Olympus Innovation Ventures, and other strategic investors. Neuspera is making an Implantable Sacral Neuromodulation (SNM) System. This discreet, ultra-miniaturized implant is designed to provide personal control and relief from urinary urge incontinence (UUI), a common symptom of overactive bladder (OAB) affecting millions of adults. OAB can significantly impact daily life, leading to issues like depression and social stigma. The Neuspera System stands out as the least invasive sacral neuromodulation device. Its innovative design includes a pulse generator and electrode array that fit snugly within the sacral foramen, eliminating the need for invasive procedures. Patients can enjoy the benefits without noticeable scars or discomfort, regaining control of their symptoms and enhancing their quality of life. This funding will support Neuspera Medical through the anticipated U.S. FDA premarket approval (PMA) of the Neuspera System. This is a step forward in providing less invasive, adaptable treatment options for chronic illnesses. CEO of Neuspera Steffen Hovard said: “We’re excited to bring new partners on board as we approach the next significant milestone of submitting the Neuspera System for regulatory approval,” “The confidence and conviction of our new and existing investors, like Olympus Innovation Ventures, demonstrates the strength and potential of our platform technology.” #neuromodulation #neurotech #funding

ViaLase, Inc. , A clinical-stage #medical technology startup called has raised $40 million in a series C round of funding with the goal of filling gaps in the current paradigm for treating glaucoma. The financing was spearheaded by a new investor, with backing from existing investors such as Arboretum Ventures, Venture Investors, Health Fund, and Falcon Vision, an ophthalmology investment platform backed by KKR. The company, led by its founder and CEO, Tibor Juhasz, PhD, plans to use the money to make sure that the ViaLase® Laser* continues to advance clinically, legally, and #commercially. The first femtosecond laser used to treat primary open angle glaucoma (POAG) will be the ViaLase Laser, if approved. The ViaLuxeTM Laser System is intended to lower intraocular pressure (IOP) by non-invasively creating customised drainage channels via the #trabecular meshwork combining #femtosecond laser accuracy and micron-accurate gonio imaging. ViaLase, Inc Hadi Srass Ferenc Raksi Carlos Suarez Read more - https://lnkd.in/gBqtkjnF To share your startup story write us on - contact@startuprise.io #ViaLase #medicalstartup #medical #technology #glaucoma #commercially #accuracy #startup #startupnews #fundingnews #news